Redeye embraces BONESUPPORT’s quarterly report, which again comes in with actual figures better than our estimates. We are particularly impressed by the strong US sales growth of 72% y/y.
ANNONS
Redeye embraces BONESUPPORT’s quarterly report, which again comes in with actual figures better than our estimates. We are particularly impressed by the strong US sales growth of 72% y/y.